Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports

Our Views
Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports
Magazine
Store

About Swarajya

Swarajya is a publication by Kovai Media Private Limited.

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Participate

Contact Us
Write for us
Style Guide
Jobs

Stay Connected

SII

Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAX

Covid-19 vaccine

India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: Report

Covaxin and Covishield

Serum Institute's Chairman Cyrus Poonawalla Bats For Booster Dose Of Covishield After Six Months

Covishield vaccine

Govt Places Order For 66 Crore COVID-19 Vaccine Doses From Serum Institute, Bharat Biotech

Covaxin and Covishield

Serum Institute Likely To Begin Clinical Trial Of Covovax On Children In India From Next Month: Report

Serum Institute of India (Pic Via Twitter)

Amid Looming Uncertainty Over EUA In US, Novavax Eyes India Launch Of Its COVID Jab With Over 90 Per Cent Efficacy

Pic Via Novavax's official Twitter handle

Govt's Expert Panel Mulls Increasing Gap Between Covishield's Two Doses To Boost Efficacy, Vaccination Drive

SII's Covishield vaccine (Pic Via Twitter)

Covishield May Offer Protection Against Double Mutant Strain: CCMB Report

Covishield vaccine (Pic Via Twitter)

Bullish Scenario For Vaccine Rollout: How India Might Achieve Herd Immunity By Dussehra

Covid-19 vaccine. (Representative image)

Lift Embargo On Vaccine Raw Material Exports: Serum Institute's Adar Poonawalla Urges US President Biden

Adar Poonawalla (Image Credits: Twitter)

The Covid-19 ‘Vaccine Shortage’: What Is Really Happening?

Vaccination drive.

WHO Approves Two Versions Of Oxford-AstraZeneca Covid-19 Vaccine Including SII's Covishield For Emergency Use

Covishield vaccine (Pic Via Twitter)

Health Ministry Says It Doesn't Agree With Calculation Of Rs 80,000 Crore For Covid-19 Vaccine Distribution

Covid-19 vaccine - representative image (Twitter)

After Oxford Covid-19 Vaccine, Serum Institute Likely To Start Clinical Trials Of Novavax's Vaccine Candidate In India

Serum Institute of India (Pic Via Twitter)

Serum Institute To Begin Human Clinical Trials Of Oxford University's Covid-19 Vaccine In India From Today

SII's Covishield vaccine (Pic Via Twitter)

Get Swarajya in your inbox.